Celeatherapeutics Director, Head of Communications to build and execute an integrated external communications program at Celea Therapeutics. Own corporate communications and support messaging around clinical and corporate milestones.
Responsibilities
Own Celea’s integrated communications workplan, ensuring external messaging is clear, consistent, scientifically credible, regulatorily appropriate, and aligned with company strategy.
Develop, write, and maintain core corporate external-facing materials, including the corporate deck, external presentation, conference materials, press releases, executive talking points, Q&A documents, website updates, and social media content.
Partner with executive leadership, Finance, Legal, Clinical, Medical Affairs, and external advisors to support corporate objectives, including conference planning together with medical affairs, Q&A preparation, and company communications processes.
Partner with Leadership and HR on internal communications, providing strategic messaging and communications support for employee announcements, program rollouts, company news and other key organizational updates.
Translate complex clinical, scientific, regulatory, and commercial information into balanced, accurate, audience-appropriate messaging for, healthcare stakeholders, media, prospective employees, patients, and caregivers.
Lead proactive and reactive communications around corporate, clinical, financing, conference, and business milestones, balancing planned news flow with opportunistic visibility opportunities between major events.
Coordinate media relations and thought leadership activities, including media lists, inbound inquiries, executive preparation, earned media opportunities, and compliant amplification of scientific congress activity and scientific data.
Oversee external communications, design, wire distribution, website, conference, and agency partners, including scopes of work, timelines, budgets, deliverable quality, and issue escalation.
Lead strategic planning for Celea’s web presence across key audiences, including patients and caregivers, healthcare providers, career seekers, investors, media, and other external stakeholders.
Create practical processes, templates, message maps, trackers, and version-control standards that allow a lean company to operate with public-company-like discipline.
Prepare the infrastructure for building Celea’s future Communications team, including scalable processes, tools, workflows, agency interfaces, and role definitions that can support team growth as the company expands.
Qualification
Bachelor’s degree in communicationsExperience preparing corporate decksExcellent writing and editing skillsFamiliarity with rare diseaseWhy Join Celea TherapeuticsWork closely with an experienced
Required
Bachelor’s degree in communications, business, finance, life sciences, journalism, or a related field; equivalent experience considered.
8+ years of experience in investor relations, corporate communications, financial communications, biotechnology or pharmaceutical communications, healthcare capital markets, or a closely related field.
Excellent writing and editing skills, with the ability to draft polished, executive-ready materials and translate complex science into concise business language.
Strong project management skills and the ability to operate independently in a fast-paced, early-stage environment with limited infrastructure and shifting priorities.
Proficiency using AI tools to work smarter, improve quality, accelerate drafting and research, and build repeatable workflows while maintaining human judgment and accountability.
Familiarity with rare disease, pulmonary, respiratory, or specialty pharmaceutical markets.
Why Join Celea Therapeutics
Play a pivotal role in advancing life-changing therapies for patients with devastating lung diseases.
Shape the communications and investor relations foundation of a Phase 3 biotech poised for significant growth.
Work closely with an experienced, mission-driven leadership team and influence how Celea tells its story to patients, investors, clinicians, employees, and the broader market.
Build a function with public-company discipline while staying close to the science, the strategy, and the people behind the mission.